Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Masquerading disease of macular telangiectasia type 2 - MacTel Project Report No 11.

Ophthalmology. Retina·2026
Same author

Die Ophthalmologie·2026
Same author

Choroidal vascularity across aging and the spectrum of age-related macular degeneration: an AI-based OCT study.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2026
Same author

Treatment of central serous chorioretinopathy in comparison-microsecond-pulse laser versus photodynamic therapy.

Die Ophthalmologie·2026
Same author

Prediction performance of random reservoirs with different topology for nonlinear dynamical systems with different number of degrees of freedom.

Chaos (Woodbury, N.Y.)·2026
Same author

[Complete lens dislocation into the anterior chamber with acute tension decompensation].

Die Ophthalmologie·2026

Related Experiment Video

Updated: May 28, 2025

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
05:14

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

Published on: August 11, 2023

998

[Secondary choroidal neovascularization-Really so common?]

Ulrike Brocks1, Martin Ziegler2, Clemens Lange2

  • 1Klinik für Augenheilkunde, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland. u.brocks@uke.de.

Die Ophthalmologie
|February 10, 2025
PubMed
Summary
This summary is machine-generated.

Secondary choroidal neovascularization (CNV) complicates chronic central serous chorioretinopathy. While anti-VEGF injections are standard, treatment response is limited, often leading to vision loss.

Keywords:
Anti-vascular endothelial growth factorCentral serous chorioretinopathyMultimodal imagingPhotodynamic therapyTherapy

More Related Videos

Detecting Abnormalities in Choroidal Vasculature in a Mouse Model of Age-related Macular Degeneration by Time-course Indocyanine Green Angiography
10:24

Detecting Abnormalities in Choroidal Vasculature in a Mouse Model of Age-related Macular Degeneration by Time-course Indocyanine Green Angiography

Published on: February 19, 2014

13.6K
An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis
06:10

An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis

Published on: August 6, 2020

5.6K

Related Experiment Videos

Last Updated: May 28, 2025

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
05:14

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

Published on: August 11, 2023

998
Detecting Abnormalities in Choroidal Vasculature in a Mouse Model of Age-related Macular Degeneration by Time-course Indocyanine Green Angiography
10:24

Detecting Abnormalities in Choroidal Vasculature in a Mouse Model of Age-related Macular Degeneration by Time-course Indocyanine Green Angiography

Published on: February 19, 2014

13.6K
An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis
06:10

An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis

Published on: August 6, 2020

5.6K

Area of Science:

  • Ophthalmology
  • Retinal Diseases
  • Neovascularization

Context:

  • Chronic central serous chorioretinopathy (cCSC) can lead to secondary choroidal neovascularization (CNV).
  • Multimodal imaging is crucial for diagnosing secondary CNV in cCSC patients.

Purpose:

  • To review the diagnostic and therapeutic landscape of secondary CNV in chronic central serous chorioretinopathy.

Summary:

  • Intravitreal anti-vascular endothelial growth factor (VEGF) injections are the primary treatment for secondary CNV.
  • Combination therapy with photodynamic therapy may offer benefits.
  • Treatment response to anti-VEGF is often reduced compared to other CNV types.

Impact:

  • Secondary CNV in cCSC frequently results in irreversible visual acuity decrease despite treatment.
  • Understanding treatment limitations is vital for managing patient expectations and outcomes.